secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001213900-24-085116
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Three NKGen Biotech directors Klowden, Park, Scott resign; board shrinks to 2
-----------------------------------------------------------------------------

- Michael Klowden, Sangwoo Park, and Kathleen Scott resigned as directors effective Sept 29, 2024, one-year anniversary of service.
- Resignations not due to any dispute with the company or board.
- Board size temporarily reduced from 5 to 2 directors; committees each reduced to 1 member.
- Board will seek new appointees within 180 days; discussions ongoing for Klowden and Scott reappointment.
- CEO Paul Y. Song thanked the departing directors for their service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/0001213900-24-085116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/ea0216077-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-085116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer